Deutsche Bank’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-226
| Closed | -$2K | – | 4207 |
|
|
2019
Q4 | $2K | Sell |
226
-428
| -65% | -$3.79K | ﹤0.01% | 4545 |
|
|
2019
Q3 | $7K | Sell |
654
-1,593
| -71% | -$17.1K | ﹤0.01% | 4332 |
|
|
2019
Q2 | $40K | Buy |
2,247
+1,228
| +121% | +$21.9K | ﹤0.01% | 4358 |
|
|
2019
Q1 | $73K | Sell |
1,019
-1,806
| -64% | -$129K | ﹤0.01% | 4261 |
|
|
2018
Q4 | $81K | Sell |
2,825
-1,225
| -30% | -$35.1K | ﹤0.01% | 4119 |
|
|
2018
Q3 | $341K | Buy |
4,050
+1,611
| +66% | +$136K | ﹤0.01% | 3906 |
|
|
2018
Q2 | $307K | Buy |
2,439
+2,242
| +1,138% | +$282K | ﹤0.01% | 4002 |
|
|
2018
Q1 | $17K | Buy |
+197
| New | +$17K | ﹤0.01% | 4633 |
|
|
2017
Q4 | – | Sell |
-18
| Closed | -$1K | – | 4455 |
|
|
2017
Q3 | $1K | Sell |
18
-164
| -90% | -$9.11K | ﹤0.01% | 4312 |
|
|
2017
Q2 | $18K | Buy |
182
+150
| +469% | +$14.8K | ﹤0.01% | 4225 |
|
|
2017
Q1 | $3K | Buy |
32
+2
| +7% | +$188 | ﹤0.01% | 4315 |
|
|
2016
Q4 | $4K | Buy |
30
+8
| +36% | +$1.07K | ﹤0.01% | 4337 |
|
|
2016
Q3 | $5K | Sell |
22
-273
| -93% | -$62K | ﹤0.01% | 4324 |
|
|
2016
Q2 | $262K | Sell |
295
-1
| -0.3% | -$888 | ﹤0.01% | 3526 |
|
|
2016
Q1 | $267K | Buy |
296
+63
| +27% | +$56.8K | ﹤0.01% | 3429 |
|
|
2015
Q4 | $328K | Buy |
233
+1
| +0.4% | +$1.41K | ﹤0.01% | 3374 |
|
|
2015
Q3 | $389K | Sell |
232
-65
| -22% | -$109K | ﹤0.01% | 3412 |
|
|
2015
Q2 | $639K | Buy |
297
+18
| +6% | +$38.7K | ﹤0.01% | 3187 |
|
|
2015
Q1 | $510K | Sell |
279
-301
| -52% | -$550K | ﹤0.01% | 3206 |
|
|
2014
Q4 | $1.38M | Buy |
580
+279
| +93% | +$666K | ﹤0.01% | 2928 |
|
|
2014
Q3 | $738K | Buy |
+301
| New | +$738K | ﹤0.01% | 3155 |
|